CLINICAL REMISSION IN SUBJECTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE OR OTHER SYNTHETIC DMARDS: A REALWORLD CLINICAL TRIAL (TOSPACE)

Sanmarti, R.Martin Mola, E.Fonseca, J. E.Veale, D. J.Escudero, A.Gonzalez, C.ToSpace Study Grp2025-01-072025-01-072017-06-010003-4967https://hdl.handle.net/10668/25421enCLINICAL REMISSION IN SUBJECTS WITH RHEUMATOID ARTHRITIS TREATED WITH SUBCUTANEOUS TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE OR OTHER SYNTHETIC DMARDS: A REALWORLD CLINICAL TRIAL (TOSPACE)conference outputopen access10.1136/annrheumdis-2017-eular.49511468-2060https://ard.bmj.com/content/annrheumdis/76/Suppl_2/840.1.full.pdf413181402477